Press Release|

SHL Group announces new joint venture

Shl Group Joint Venture With Connectmesmart1 800x480

SHL Group is pleased to announce a new joint venture (JV) called “SHL Connect” between SHL Group and ConnectMeSmart GmbH.

The primary objective for SHL Connect is to investigate the market for connectivity and emerging technologies and explore their potential application within each of SHL Group’s companies.

Commenting on the announcement Roger Samuelsson, President and CEO of SHL Group, said: “The world around us is evolving at an incredible pace. More and more people are embracing technology as part of their daily lives, and we see some exciting opportunities for the customers and end-users of our products in building a more connected community. This JV will help us stay up to date with technological advances so that we can continue offering best in class products and services.”

The miniaturization and reduction in the cost of technology are producing a wave of products that are more interactive, more engaging, and more informative. SHL sees an opportunity to generate value for stakeholders by partnering with companies like ConnectMeSmart who have experience in these fields.

“Based on my experience working with NFC, Bluetooth Low Energy, and iBeacon connectivity in packaging and merchandising solutions, there are some exciting opportunities when it comes to new, low-cost sensors, smart technology, and data analytics. I’m looking forward to exploring these and other technologies and their potential applications within SHL Group,” says Markus Bauss, CEO of ConnectMeSmart.

In an effort to streamline customer communication, SHL Connect will coordinate directly with SHL’s global business development teams – providing regular updates on their activities. This approach enables partners from all business units to discuss potential connectivity projects through their existing contact windows.

Markus Bauss will be presenting on behalf of SHL Connect at Management Forum’s “Connectivity in Medical Technology” conference held at The Rembrandt Hotel, London on June 24-25, 2015.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News